These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19136199)

  • 21. Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941.
    Escudier B; Choueiri TK; Oudard S; Szczylik C; Négrier S; Ravaud A; Chevreau C; Venner P; Champagne P; Croteau D; Dupont E; Hariton C; Bukowski RM
    J Urol; 2007 Nov; 178(5):1901-5. PubMed ID: 17868728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
    Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real indications for adrenalectomy in renal cell carcinoma.
    Moudouni SM; En-Nia I; Patard JJ; Manunta A; Guillé F; Lobel B
    Scand J Urol Nephrol; 2002; 36(4):273-7. PubMed ID: 12201919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors of renal cell carcinoma with extension into inferior vena cava.
    Tanaka M; Fujimoto K; Okajima E; Tanaka N; Yoshida K; Hirao Y
    Int J Urol; 2008 May; 15(5):394-8. PubMed ID: 18452454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
    Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K
    J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival.
    Taccoen X; Valeri A; Descotes JL; Morin V; Stindel E; Doucet L; Joulin V; Bocqueraz F; Coulange C; Rambeaud JJ; Fournier G; Mejean A;
    Eur Urol; 2007 Apr; 51(4):980-7. PubMed ID: 17092632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors for survival in patients with brain metastases from renal cell carcinoma.
    Culine S; Bekradda M; Kramar A; Rey A; Escudier B; Droz JP
    Cancer; 1998 Dec; 83(12):2548-53. PubMed ID: 9874462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal cell carcinoma in young compared to older patients: comparison of clinicopathological risk factors and survival.
    Thoroddsen A; Einarsson GV; Hardarson S; Petursdottir V; Magnusson J; Jonsson E; Gudbjartsson T
    Scand J Urol Nephrol; 2008; 42(2):121-5. PubMed ID: 18365922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma.
    Kwak C; Park YH; Jeong CW; Jeong H; Lee SE; Moon KC; Ku JH
    J Surg Oncol; 2007 Mar; 95(4):317-23. PubMed ID: 17066434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pulmonary resections for metastatic renal cell carcinoma in Iceland].
    Oddsson SJ; Isaksson HJ; Jonsson E; Einarsson GV; Gudbjartsson T
    Laeknabladid; 2008 May; 94(5):377-81. PubMed ID: 18460734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
    Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
    Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence.
    Eggener SE; Yossepowitch O; Pettus JA; Snyder ME; Motzer RJ; Russo P
    J Clin Oncol; 2006 Jul; 24(19):3101-6. PubMed ID: 16809736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiologic trends in renal cell carcinoma in the cytokine and post-cytokine eras: a registry analysis of 28,252 patients.
    Shek D; Tomlinson B; Brown M; Brunson A; Pan CX; Lara PN
    Clin Genitourin Cancer; 2012 Jun; 10(2):93-8. PubMed ID: 22382008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine therapy in patients with renal cell carcinoma.
    Van Poppel H; Joniau S; Van Gool SW
    Eur Urol; 2009 Jun; 55(6):1333-42. PubMed ID: 19201522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastatic renal cell carcinoma: results of a population-based study with 25 years follow-up.
    Schlesinger-Raab A; Treiber U; Zaak D; Hölzel D; Engel J
    Eur J Cancer; 2008 Nov; 44(16):2485-95. PubMed ID: 18783939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of body mass index on prognosis of Japanese patients with renal cell carcinoma.
    Awakura Y; Nakamura E; Ito N; Yamasaki T; Kamba T; Kamoto T; Ogawa O
    Urology; 2007 Jul; 70(1):50-4. PubMed ID: 17656207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. External validation of an international multicenter study to predict survival in Korean patients with pT2N0M0 renal cell carcinoma.
    Ku JH; Moon KC; Kwak C; Kim HH
    Urology; 2009 Aug; 74(2):359-63. PubMed ID: 19501879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
    Dimarco DS; Lohse CM; Zincke H; Cheville JC; Blute ML
    Urology; 2004 Sep; 64(3):462-7. PubMed ID: 15351571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic factors in patients with metastatic renal cell carcinoma].
    Inoue R; Takahashi A; Takasugi S; Masumori N; Tsukamoto T; Hasegawa T
    Hinyokika Kiyo; 2010 Feb; 56(2):75-9. PubMed ID: 20185990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.